HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient.

Abstract
A 58-year-old lung transplant patient developed worsening shortness of breath and indurated erythematous plaques on the lower left leg. A skin biopsy specimen revealed a dense angiocentric and angioinvasive infiltrate in the mid to reticular dermis and panniculus containing large, atypical lymphocytes with convoluted nuclei and prominent nucleoli. Immunohistochemical stains showed that the atypical cells were of B-cell origin, and that Epstein-Barr virus was present. Molecular studies demonstrated B-cell clonality. The patient was successfully treated with rituximab. The clinical and pathologic features in this case represent posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis. The case also highlights the importance of clinical and pathologic examination of cutaneous lesions in the evaluation of lymphoproliferative disorders for patients undergoing transplantation.
AuthorsEun Ji Kwon, Kenneth A Katz, Karla S Draft, John T Seykora, Alain H Rook, Mariusz A Wasik, Jacqueline M Junkins-Hopkins
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 54 Issue 4 Pg. 657-63 (Apr 2006) ISSN: 1097-6787 [Electronic] United States
PMID16546589 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural)
Topics
  • Epstein-Barr Virus Infections (complications)
  • Humans
  • Lung Diseases (etiology, pathology)
  • Lung Transplantation (adverse effects)
  • Lymphomatoid Granulomatosis (etiology, pathology)
  • Lymphoproliferative Disorders (etiology, pathology, virology)
  • Male
  • Middle Aged
  • Skin (pathology)
  • Skin Diseases (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: